Adamas to Present at Upcoming BofA Conference
April 29 2021 - 4:04PM
Business Wire
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated
to developing and delivering medicines that make a meaningful
difference to people affected by neurological diseases, today
announced that Neil F. McFarlane, Chief Executive Officer, will
participate in a fireside chat at the BofA Securities 2021 Virtual
Health Care Conference on May 11, 2021.
The fireside chat will be webcast live on Tuesday, May 11, 2021
at 11:45 am Eastern Time on the investor relations section of the
Adamas website at http://ir.adamaspharma.com/events-presentations.
The replay will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines
that reduce the burden of neurological diseases on patients,
caregivers and, society. We are a fully-integrated company focused
on growing a portfolio of therapies to address a range of
neurological diseases. For more information, please visit
www.adamaspharma.com.
Source: Adamas Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210429005319/en/
Media: Sarah Mathieson Vice President, Corporate
Communications 510-450-3528 smathieson@adamaspharma.com
Investors: Peter Vozzo Managing Director Westwicke/ICR
443-213-0505 peter.vozzo@westwicke.com
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From Aug 2023 to Aug 2024